Table 4.
TAE | Precision (SD) | Recall (SD) | F1 (SD) | Specificity (SD) | Accuracy (SD) | N | PRR025 | Lab | Max |
---|---|---|---|---|---|---|---|---|---|
FAERS | 0.57 (0.14) | 0.78 (0.2) | 0.64 (0.13) | 0.61 (0.18) | 0.69 (0.10) | 78 | 1.06 | NA | F1 |
Labels | 0.67 (0.17) | 0.75 (0.18) | 0.68 (0.12) | 0.72 (0.16) | 0.74 (0.11) | NA | NA | 0.18 | F1 |
FAERS + labels | 0.67 (0.15) | 0.81 (0.15) | 0.71 (0.10) | 0.71 (0.19) | 0.76 (0.09) | 170 | 1.52 | 0.45 | F1 |
F1, harmonic mean of precision and recall; FAERS, US Food and Drug Administration Adverse Event Reporting System; FDA, US Food and Drug Administration; Lab, label score; Max, the performance metric maximized by the genetic algorithm; N, case count; NA, not applicable; PRR025, proportional reporting ratio lower bound of 95% confidence interval; TAE, target adverse‐event profile(s) used.
Performance is compared for three sets of predictions: (i) target‐adverse events profiles generated from FAERS data only; (ii) target‐adverse events profiles generated from the FDA label data only; (iii) target‐adverse events generated from a combination of the FAERS and the FDA labels. A genetic algorithm was used to specify N, PRR025, and label score to maximize F1.